Home > Quotes > GSK > Company Financials

GSK Company Financials

GSK 
$52.22
*  
0.11
  negative  
0.21%
Get GSK Alerts
*Delayed - data as of May 17, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$295,623 $267,474 $310,746 $327,094
Cost of Revenue
$132,135 $110,952 $133,206 $150,326
Gross Profit
$163,488 $156,522 $177,540 $176,768
Operating Expenses
Research and Development
$57,881 $63,591 $67,934 $77,358
Sales, General and Admin.
$142,853 $109,572 $114,773 $130,838
Non-Recurring Items
$1,845 $0 $0 $1,730
Other Operating Items
$0 $0 $0 $0
Operating Income
($39,091) ($16,641) ($5,167) ($33,158)
Add'l income/expense items
($265) ($6,302) $4,810 $20,036
Earnings Before Interest and Tax
($39,356) ($22,943) ($357) ($13,122)
Interest Expense
$7,193 $3,813 $7,706 $10,945
Earnings Before Tax
($46,549) ($26,756) ($8,063) ($24,067)
Income Tax
($35,853) $1,405 $2,170 ($158)
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($10,696) ($28,161) ($10,233) ($23,909)
Net Income
($10,696) ($28,161) ($10,233) ($23,909)
Net Income Applicable to Common Shareholders
($10,696) ($28,161) ($10,233) ($23,909)

See also: Company Financials data entry page